Delivering patient-centered care through shared decision making in overactive bladder
- PMID: 35332575
- PMCID: PMC9169772
- DOI: 10.1002/nau.24915
Delivering patient-centered care through shared decision making in overactive bladder
Abstract
Introduction: Men and women living with overactive bladder (OAB) face many treatment decisions as they progress through the treatment pathway. Decisions to pursue specific therapies are highly preference sensitive and ideal for shared decision making (SDM). The aim of this narrative review is to provide urologists with a practical summary of methods to elicit preferences and facilitate SDM to promote patient-centered care for OAB.
Methods: We explore OAB as a preference sensitive condition through a review of treatment outcomes and present available data on prediction tools, patient preferences, and decision aids. We propose a paradigm for applying Everyday SDM to OAB care.
Results: Clinical outcome data points to equipoise (balanced outcomes) between options for first-, second-, and third-line OAB therapies, making OAB preference sensitive and appropriate for SDM. Methods to personalize care through individualized outcome prediction calculators and tools to elicit patient preferences are emerging. While patient information about OAB is readily available, we identified few OAB decision aids that facilitate patient preference elicitation and SDM.
Conclusions: OAB is a preference sensitive condition, where treatment is largely based on the patient's preferences and values. SDM is an ideal approach to supporting patients through these treatment decisions. We propose the application of Everyday SDM, a personalized, clinically efficient methodology as a method to support patient-centered OAB care.
Keywords: discrete choice experiments; overactive bladder care; patient-centered care; patient-provider communication; preference elicitation; preference-sensitive condition; shared decision making.
© 2022 The Authors. Neurourology and Urodynamics published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Patient preference elicitation instrument, OABCare, to facilitate shared decision-making in the care of overactive bladder.Neurourol Urodyn. 2021 Mar;40(3):791-801. doi: 10.1002/nau.24618. Epub 2021 Feb 10. Neurourol Urodyn. 2021. PMID: 33565118 Clinical Trial.
-
Shifts in patient preference of third-line overactive bladder therapy after introduction of the implantable tibial nerve stimulator.Neurourol Urodyn. 2024 Apr;43(4):959-966. doi: 10.1002/nau.25421. Epub 2024 Feb 23. Neurourol Urodyn. 2024. PMID: 38390786
-
Decisions With Patients, Not for Patients: Shared Decision-Making in Allergy and Immunology.J Allergy Clin Immunol Pract. 2024 Oct;12(10):2625-2633. doi: 10.1016/j.jaip.2024.05.046. Epub 2024 Jun 6. J Allergy Clin Immunol Pract. 2024. PMID: 38851489 Review.
-
Patient Perceptions Impact Progression to Third-Line Therapy for Treatment of Overactive Bladder.J Urol. 2021 Nov;206(5):1240-1247. doi: 10.1097/JU.0000000000001950. Epub 2021 Jun 29. J Urol. 2021. PMID: 34184922
-
The Effects of Shared Decision Making on Cancer Screening – A Systematic Review [Internet].Washington (DC): Department of Veterans Affairs (US); 2014 Sep. Washington (DC): Department of Veterans Affairs (US); 2014 Sep. PMID: 26290937 Free Books & Documents. Review.
Cited by
-
Patient and physician decision-making dynamics in overactive bladder care: A mixed methods study.Neurourol Urodyn. 2024 Mar;43(3):565-573. doi: 10.1002/nau.25416. Epub 2024 Feb 9. Neurourol Urodyn. 2024. PMID: 38334205 Free PMC article.
-
A real-world evidence study of interhospital variability in the surgical treatment of patients with benign prostatic hyperplasia: the REVALURO study.Int Urol Nephrol. 2025 Mar;57(3):775-784. doi: 10.1007/s11255-024-04239-7. Epub 2024 Oct 29. Int Urol Nephrol. 2025. PMID: 39470938 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical